In September of 1990 Gene therapy was delivered to its first patient, a four-year old girl suffering from adenosine deaminase deficiency. Research on Gene therapy had begun in 1985 when trying to discover a new way to deliver a human gene via a retrovirus. Since its creation, Gene therapy has been met with major push back based on its ethical concerns. However, it has also been proven through clinical trials to be an effective way of treating diseases we have not had the methods to be able to treat. This presentation reviews the techniques associated with Gene therapy as well as a review of a few of the clinical trials. It also addresses some of the ethical concerns and the regulations in the United States. The further development of Gene therapy could change the course of people’s lives who currently live with untreatable diseases.
BIOL 499, Capstone
Paul Allee
11 – 11:30 AM
Join the Zoom discussion afterward. The presenter and faculty advisor both have the password.